Tourmaline Bio Inc
NASDAQ:TRML
Income Statement
Earnings Waterfall
Tourmaline Bio Inc
Income Statement
Tourmaline Bio Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(23)
|
(27)
|
(33)
|
(40)
|
(48)
|
(57)
|
(64)
|
(71)
|
(76)
|
(75)
|
(66)
|
(56)
|
(45)
|
(39)
|
(44)
|
(59)
|
(90)
|
(98)
|
(102)
|
|
| Selling, General & Administrative |
(7)
|
(9)
|
(11)
|
(12)
|
(13)
|
(15)
|
(17)
|
(18)
|
(19)
|
(21)
|
(22)
|
(27)
|
(13)
|
(13)
|
(13)
|
(9)
|
(23)
|
(23)
|
(23)
|
|
| Research & Development |
(15)
|
(18)
|
(22)
|
(28)
|
(34)
|
(42)
|
(47)
|
(53)
|
(57)
|
(53)
|
(44)
|
(29)
|
(32)
|
(30)
|
(42)
|
(61)
|
(67)
|
(76)
|
(80)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
11
|
11
|
0
|
0
|
0
|
|
| Operating Income |
(23)
N/A
|
(27)
-18%
|
(33)
-24%
|
(40)
-21%
|
(48)
-19%
|
(57)
-20%
|
(64)
-13%
|
(71)
-10%
|
(76)
-8%
|
(75)
+2%
|
(66)
+12%
|
(56)
+16%
|
(45)
+19%
|
(39)
+14%
|
(44)
-14%
|
(59)
-34%
|
(90)
-51%
|
(98)
-9%
|
(102)
-4%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(7)
|
(14)
|
(14)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
0
|
1
|
2
|
3
|
4
|
5
|
3
|
5
|
8
|
11
|
17
|
16
|
14
|
|
| Pre-Tax Income |
(23)
N/A
|
(27)
-20%
|
(34)
-25%
|
(40)
-19%
|
(48)
-18%
|
(57)
-19%
|
(64)
-12%
|
(70)
-10%
|
(74)
-6%
|
(78)
-6%
|
(75)
+4%
|
(63)
+16%
|
(42)
+33%
|
(33)
+22%
|
(35)
-7%
|
(48)
-37%
|
(73)
-51%
|
(82)
-12%
|
(88)
-7%
|
|
| Net Income | ||||||||||||||||||||
| Income from Continuing Operations |
(23)
|
(27)
|
(34)
|
(40)
|
(48)
|
(57)
|
(64)
|
(70)
|
(74)
|
(78)
|
(75)
|
(63)
|
(42)
|
(33)
|
(35)
|
(48)
|
(73)
|
(82)
|
(88)
|
|
| Net Income (Common) |
(23)
N/A
|
(27)
-20%
|
(34)
-25%
|
(40)
-19%
|
(48)
-18%
|
(57)
-19%
|
(64)
-12%
|
(70)
-10%
|
(74)
-6%
|
(78)
-6%
|
(75)
+4%
|
(63)
+16%
|
(42)
+33%
|
(33)
+22%
|
(35)
-7%
|
(48)
-37%
|
(73)
-51%
|
(82)
-12%
|
(88)
-7%
|
|
| EPS (Diluted) |
-5.51
N/A
|
-6.59
-20%
|
-8.21
-25%
|
-9.91
-21%
|
-11.69
-18%
|
-13.85
-18%
|
-15.47
-12%
|
-16.81
-9%
|
-17.93
-7%
|
-18.69
-4%
|
-17.72
+5%
|
-14.7
+17%
|
-8.84
+40%
|
-1.36
+85%
|
-1.35
+1%
|
-1.85
-37%
|
-2.92
-58%
|
-3.15
-8%
|
-3.38
-7%
|
|